PAX3 and rhabdomyosarcoma: Silencing or pharmacological inhibition of PCAF in alveolar rhabdomyosarcoma resulted in the down-regulation of PAX3-FOXO1 reduced proliferation and tumor burden in xenograft mice models [75].